Collet, Carlos
Capodanno, Davide
Onuma, Yoshinobu
Banning, Adrian
Stone, Gregg W.
Taggart, David P.
Sabik, Joseph
Serruys, Patrick W.
Article History
First Online: 29 March 2018
Change Date: 21 February 2020
Change Type: Update
Change Details: This article has been modified to correct the resolution of the arrows depicting shear stress in Figure 2. The figure has been updated in the HTML and PDF versions of the manuscript.
Competing interests
: C.C. received research grants from Biosensors and HeartFlow. D.C. received speaker and consulting honoraria from Abbott Vascular, AstraZeneca, Bayer, Daiichi Sankyo, and Stentys. Y.O. is a member of the advisory board of Abbott Vascular. A.B. received lecture fees from Abbott Vascular, Boston Scientific, and Medtronic and grant support from Boston Scientific. G.W.S. received consulting fees from Ablative Solutions, Matrizyme, Medical Development Technologies, Miracor, Neovasc, TherOx, Reva, Toray, Vascular Dynamics, Velomedix, and V-Wave; served as a consultant on prasugrel patent litigation paid for by Lupin Pharmaceuticals; and holds equity, stock options, or both in the Aria, Biostar family of funds, Cagent, Caliber Therapeutics, Guided Delivery Systems, MedFocus family of funds, MiCardia, Qool Therapeutics, and Vascular Nanotransfer Technologies. Columbia University (G.W.S.) received royalties from Abbott Vascular for the sale of MitraClip. D.P.T. served as advisor and speaker for Abbott Laboratories, Medtronic, and Novadaq Technologies; and owns stock, stock option, or bonds from Novadaq Technologies. J.S. received fees for serving on advisory boards from Medtronic and the Sorin Group, training fees from Medtronic, and research funding from Abbott and Edwards Lifesciences. P.W.S. received consulting fees from Abbott, AstraZeneca, Biotronik, Cardialysis, GLG Research, Medtronic, SINO Medical Sciences Technology, St. Jude Medical, Stentys France, Svelte Medical Systems, and Volcano.